Preconditioning diabetic mesenchymal stem cells with myogenic medium increases their ability to repair diabetic heart

INTRODUCTION: Mesenchymal stem cells (MSCs) have the potential for treatment of diabetic cardiomyopathy; however, the repair capability of MSCs declines with age and disease. MSCs from diabetic animals exhibit impaired survival, proliferation, and differentiation and therefore require a strategy to...

Descripción completa

Detalles Bibliográficos
Autores principales: Khan, Mohsin, Ali, Fatima, Mohsin, Sadia, Akhtar, Shoaib, Mehmood, Azra, Choudhery, Mahmood S, Khan, Shaheen N, Riazuddin, Sheikh
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2013
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3707006/
https://www.ncbi.nlm.nih.gov/pubmed/23706645
http://dx.doi.org/10.1186/scrt207

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3707006/
https://www.ncbi.nlm.nih.gov/pubmed/23706645
http://dx.doi.org/10.1186/scrt207

Ejemplares similares